Targeted deletion of the 9p21 non-coding coronary artery disease risk interval in mice.
about
Non-coding RNA ANRIL and the number of plexiform neurofibromas in patients with NF1 microdeletionsIntegrative annotation of variants from 1092 humans: application to cancer genomicsEpigenetic regulation of the INK4b-ARF-INK4a locus: in sickness and in healthLong noncoding RNA in genome regulation: prospects and mechanismsAbdominal aortic aneurysm is associated with a variant in low-density lipoprotein receptor-related protein 1Genome-wide association study of intracranial aneurysm identifies three new risk lociLong non-coding RNA ANRIL is required for the PRC2 recruitment to and silencing of p15(INK4B) tumor suppressor geneGenomics era and complex disorders: Implications of GWAS with special reference to coronary artery disease, type 2 diabetes mellitus, and cancersMechanisms of long noncoding RNA function in development and diseaseExpanding Horizons for Abdominal Aortic AneurysmsThe association of 9p21-3 locus with coronary atherosclerosis: a systematic review and meta-analysisIdentifying novel biomarkers for cardiovascular disease risk predictionHuman genetics of diabetic vascular complicationsDNA damage and repair in atherosclerosis: current insights and future perspectivesLong non-coding RNAs and complex human diseasesFunctional anatomy of distant-acting mammalian enhancersGenome-wide association studies of late-onset cardiovascular diseaseThe gene desert mammary carcinoma susceptibility locus Mcs1a regulates Nr2f1 modifying mammary epithelial cell differentiation and proliferationMultiple knockout mouse models reveal lincRNAs are required for life and brain developmentThe short and long of noncoding sequences in the control of vascular cell phenotypesANRIL: molecular mechanisms and implications in human healthCommon genetic variants in the 9p21 region and their associations with multiple tumoursEffect of 9p21.3 coronary artery disease locus neighboring genes on atherosclerosis in miceBone marrow p16INK4a-deficiency does not modulate obesity, glucose homeostasis or atherosclerosis developmentLarge scale association analysis identifies three susceptibility loci for coronary artery diseaseGenetics and beyond--the transcriptome of human monocytes and disease susceptibilityGenome-wide association study for intracranial aneurysm in the Japanese population identifies three candidate susceptible loci and a functional genetic variant at EDNRAGenome-wide association study of intracranial aneurysms confirms role of Anril and SOX17 in disease risk.Long noncoding RNA variations in cardiometabolic diseases.Islet biology, the CDKN2A/B locus and type 2 diabetes risk.An intergenic region on chromosome 13q33.3 is associated with the susceptibility to kidney disease in type 1 and 2 diabetes.Expression of linear and novel circular forms of an INK4/ARF-associated non-coding RNA correlates with atherosclerosis risk.Genome-wide identification of expression quantitative trait loci (eQTLs) in human heartGenetic variants at chromosome 9p21 and risk of first versus subsequent coronary heart disease events: a systematic review and meta-analysis.Towards a molecular systems model of coronary artery diseaseIntegrated genomics of susceptibility to alkylator-induced leukemia in miceCDKN2B Methylation and Aortic Arch Calcification in Patients with Ischemic StrokeCombining genome-wide data from humans and animal models of dyslipidemia and atherosclerosis.Roles of lncRNAs in pancreatic beta cell identity and diabetes susceptibility.Comparing strategies to fine-map the association of common SNPs at chromosome 9p21 with type 2 diabetes and myocardial infarction.
P2860
Q21261481-84B0412C-7617-461B-B0BE-DEFE4924B49DQ22065599-475C39CC-9103-4375-AAD4-5F4514B58E75Q24604190-6E1BEDA0-D7FA-43EC-ABA3-278B0BC61C66Q24621946-1D6947AE-0098-4684-A0C5-0F3300750B37Q24629883-3BCBD3B8-5ABD-4FF2-A46B-4DF2AFC15126Q24630663-EC2FA0D7-A001-4156-A774-9CC07C003932Q24632383-95069DA9-ABC8-4D26-9F63-D83ABF3E5982Q26740000-BE076A1C-9F8E-4D73-B35E-4AD230FBE389Q26752329-3A76DE4D-8AB6-4844-BD91-9E979096B5F3Q26769654-65D03907-027A-4162-87EB-24467A5254D2Q26865219-192DE1CE-B699-43CE-A268-6E2E4153BBA4Q26865722-BFD73B4B-4311-4C40-9F03-8F2B3AF6F554Q27000709-E90FC263-F4DB-4C4D-8A86-DE9492354407Q27001756-FC473E1C-01F7-4435-9E1C-04F41B2C1F77Q27004718-57105DFA-C9EC-4668-A93F-DE001761244FQ27005836-1ABDF82B-4AF8-43D1-B59C-80421BDF364CQ27012711-7C0FFB70-F8B1-4096-9582-68C21815A824Q27322396-126A786A-C78E-459E-B7B0-1AF364ECA7C8Q28044579-60C72E5E-2F87-4780-9439-CDC9ED8A81A0Q28080857-11667F5E-3B51-4854-9BA9-FC6112C32796Q28394102-C38B02F8-8AA9-4371-9CA2-E52B62E65030Q28396581-E38A28AD-2C5E-4905-92B4-BACA55EAC70BQ28513259-FDA5F546-A631-4E7A-A288-79C7A866B427Q28731544-E8E87E18-724E-4912-AF95-BBC1C302A3CBQ28740844-DD12E5FE-A5F1-4212-9C59-227F2D8CF0A0Q28752094-65B0ED59-7208-4C3D-B788-46675F444B61Q28943344-A2FC7E75-306B-4EE2-9C0D-25FA9A9B33E1Q29417123-993B756B-9A30-4BF4-8E9A-5B40513C54A6Q30249603-31558DB2-2170-442F-96CF-8EF9C8126623Q30251397-BEC1A3EE-9935-4B3C-914C-73B189C10496Q30417141-33D55427-2FB1-459E-8A7D-5F608397659EQ30433884-35BC822F-47FD-4C0B-80EA-F07D871B6FABQ33638413-864CD34E-8FE5-4D8D-81AD-63E7B25A081BQ33673402-27DA4183-B283-4B45-AFD2-298ADA686E22Q33729494-98FD2D20-F1A9-4948-99A6-2EE4D999F599Q33748270-1A335595-E0C2-4C80-AF41-BAEE08A490F1Q33752280-387CAE0E-82F6-4A57-AD96-67B9C1B06BC4Q33778131-E5572B45-05F2-46E9-9A14-A6CAE86CAA2EQ33827444-01989B8A-5632-4F15-8CF2-8B37185CC36CQ33897245-3E6342F3-A00D-4B9B-89E9-4288411A261B
P2860
Targeted deletion of the 9p21 non-coding coronary artery disease risk interval in mice.
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Targeted deletion of the 9p21 non-coding coronary artery disease risk interval in mice.
@ast
Targeted deletion of the 9p21 non-coding coronary artery disease risk interval in mice.
@en
Targeted deletion of the 9p21 non-coding coronary artery disease risk interval in mice.
@nl
type
label
Targeted deletion of the 9p21 non-coding coronary artery disease risk interval in mice.
@ast
Targeted deletion of the 9p21 non-coding coronary artery disease risk interval in mice.
@en
Targeted deletion of the 9p21 non-coding coronary artery disease risk interval in mice.
@nl
prefLabel
Targeted deletion of the 9p21 non-coding coronary artery disease risk interval in mice.
@ast
Targeted deletion of the 9p21 non-coding coronary artery disease risk interval in mice.
@en
Targeted deletion of the 9p21 non-coding coronary artery disease risk interval in mice.
@nl
P2093
P2860
P50
P356
P1433
P1476
Targeted deletion of the 9p21 non-coding coronary artery disease risk interval in mice.
@en
P2093
Elaine Gong
Jonathan C Cohen
Len A Pennacchio
Veena Afzal
P2860
P2888
P304
P356
10.1038/NATURE08801
P407
P577
2010-02-21T00:00:00Z
P5875
P6179
1013541081